Fundraising Fox

Regenacy Pharmaceuticals

Waltham, US · Founded 2016 · Delaware corporation

Biotech

Founders & leadership

SJ
Simon JonesPresident and Chief Executive Officer
MC
Marc CohenSecretary, Treasurer and Executive Chair
JR
John RochaChief Financial Officer
ML
Michael L. HuangNamed on SEC filing
WC
William ChinNamed on SEC filing
SY
Shixiang YanNamed on SEC filing
DW
Daguang WangNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$28.7M disclosed across 2 rounds · 2020–2022

▶$7.8MraisedFeb 2022 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Daguang WangDirector
  • William ChinDirector
  • Simon JonesExecutive Officer, Director
  • Shixiang YanDirector
  • Michael L. HuangDirector
  • Marc CohenExecutive Officer, Director
  • John RochaExecutive Officer
Offering amount
$10M
Amount sold
$7.8M
First sale
Jan 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20.9MraisedApr 2020 · 19 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael L. HuangDirector
  • Simon JonesExecutive Officer, Director
  • William ChinDirector
  • Shixiang YanDirector
  • Daguang WangDirector
  • Marc CohenExecutive Officer, Director
  • John RochaExecutive Officer
Offering amount
$40.7M
Amount sold
$20.9M
Sales commissions
$757.5K
Placement agents
Locust Walk Partners, LLC
First sale
Mar 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Regenacy Pharmaceuticals raised?
Regenacy Pharmaceuticals has disclosed $28.7M raised across 2 rounds.
Where is Regenacy Pharmaceuticals headquartered?
Regenacy Pharmaceuticals is headquartered in Waltham, US.